Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Daniela, Lamers"'
Autor:
Giulia Lizzo, Eugenia Migliavacca, Daniela Lamers, Adrien Frézal, John Corthesy, Gerard Vinyes-Parès, Nabil Bosco, Leonidas G. Karagounis, Ulrike Hövelmann, Tim Heise, Maximilian von Eynatten, Philipp Gut
Publikováno v:
Frontiers in Aging, Vol 3 (2022)
Glycine and cysteine are non-essential amino acids that are required to generate glutathione, an intracellular tripeptide that neutralizes reactive oxygen species and prevents tissue damage. During aging glutathione demand is thought to increase, but
Externí odkaz:
https://doaj.org/article/3cb8b258691640c6b12f20b7acfe4d07
Autor:
Arvid Jungnik, Jorge Arrubla Martinez, Leona Plum‐Mörschel, Christoph Kapitza, Daniela Lamers, Claus Thamer, Corinna Schölch, Michael Desch, Anita M. Hennige
Publikováno v:
Diabetes, Obesity and Metabolism. 25:1011-1023
Autor:
Arvid, Jungnik, Jorge, Arrubla, Leona, Plum-Mörschel, Christoph, Kapitza, Daniela, Lamers, Claus, Thamer, Corinna, Schoelch, Michael, Desch, Anita M, Hennige
Publikováno v:
Diabetes, obesitymetabolism.
To report two Phase I studies of the novel subcutaneous glucagon-like peptide-1 receptor/glucagon receptor (GLP-1R/GCGR) dual agonist BI 456906 versus placebo in healthy volunteers and people with overweight/obesity.A Phase Ia study (NCT03175211) inv
Autor:
null Arvid Jungnik, null Jorge Arrubla, null Leona Plum‐Mörschel, null Christoph Kapitza, null Daniela Lamers, null Claus Thamer, null Corinna Schoelch, null Michael Desch, null Anita M. Hennige
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98723b5cc5f26b186448dcade1dbaad6
https://doi.org/10.1111/dom.14948/v2/response1
https://doi.org/10.1111/dom.14948/v2/response1
Autor:
Daniela Lamers, Ulrik Mouritzen, Ulrike Hövelmann, Tim Heise, Minna Braendholt Olsen, Birgit Kronshage
Publikováno v:
Diabetes, Obesity & Metabolism
AIM To characterize the pharmacokinetic and pharmacodynamic properties of dasiglucagon, a novel, stable and liquid formulated glucagon analogue, during hypoglycaemic and euglycaemic conditions in adult patients with type 1 diabetes mellitus. RESEARCH
Autor:
Aymeric Ranson, Martin Gaudier, Cyril Seroussi, Tim Heise, Bertrand Alluis, J. Hans DeVries, Grit Andersen, Grégory Meiffren, Olivier Soula, Daniela Lamers
Publikováno v:
Diabetes, obesity & metabolism, 20(11), 2627-2632. Wiley-Blackwell
Aim To investigate the safety and efficacy of BioChaperone Lispo (BCLIS), an ultra-rapid formulation of insulin lispro (LIS) in people with type 1 diabetes. Materials and methods In this randomized, double-blind study, participants self-administered
Autor:
Ulrike Hövelmann, Daniela Lamers, Britta Væver Bysted, Tim Heise, Francesca Macchi, Birgit Kronshage, Daniél Vega Møller, Ulrik Mouritzen
Publikováno v:
Diabetes Care. 41:531-537
OBJECTIVE Treatment of severe hypoglycemia outside of the hospital setting is limited to glucagon formulations requiring reconstitution before use, which may lead to erroneous or delayed glucagon administration. We compared the pharmacokinetic (PK) a
Autor:
Marion Odoul, Ulrike Hövelmann, Daniela Lamers, José Correia, Olivier Soula, Martin Gaudier, Eric Zijlstra, Stanislav Glezer, Sophie Teng, David Duracher
Publikováno v:
Diabetes. 67
BCG is a stable, ready-to-inject, aqueous formulation of human glucagon for hypoglycemia rescue therapy. In this randomized, double-blind, crossover trial we investigated the safety and efficacy of two BCG formulations vs. a commercially available gl
Autor:
Daniela Lamers, Minna Braendholt Olsen, Ulrik Mouritzen, Birgit Kronshage, Tim Heise, Ulrike Hövelmann
Publikováno v:
Diabetes. 67
To develop a dual hormone artificial pancreas (DHAP) a liquid stable glucagon component is needed. Currently available glucagon products have limited stability after reconstitution and are therefore not suited for DHAP usage. Dasiglucagon is a novel
Publikováno v:
Archives of Physiology and Biochemistry. 121:81-87
Adipose tissue is not only releasing lipids but also various adipokines that are both dysregulated in the obese state and may contribute to obesity-associated vascular dysfunction and cardiovascular risk. We have previously shown that the combination